CAS 859-18-7 Medicine Raw Materials API Lincomycin HCl for Animals with GMP ISO

• Varieties: Growth Promoting Medicine
• Component: Chemical Synthetic Drugs
• Type: The First Class
• Pharmacodynamic Influential Factors: Incompatibility
• Storage Method: Light Proof
• Transport Package: 25kg/Bag
• Model NO.: powder
• Specification: 25kg/bag
• Trademark: Moosun
• Origin: China
• Production Capacity: 30000 Tons /Year

Product Description

Lincomycin hydrochloride Introduction

Lincomycin hydrochloride is a semi-synthetic chlorinated derivative of lincomycin and is indicated for the treatment of various infectious diseases caused by gram-positive and anaerobic bacteria and also for the treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Application:
1. Oral formulations is suitable for treating respiratory infections, abdominal infection, female reproductive tract infections, pelvic infections, skin and soft tissue infections caused by sensitive Staphylococcus aureus and Streptococcus pneumoniae. 
2. In addition to the treatment of the above infections, injected formulations are suitable for treatment of severe infections caused by streptococcus, pneumococcus and staphylococcus such as the surgical adjuvant therapy of septicemia, bone and joint infections, chronic bone and joint infections and Staphylococcus-induced acute hematogenous osteomyelitis. 
3. Lincomycin hydrochloride may also be used for the treatment of infectious diseases in patients allergic to penicillin or not suitable for administration of penicillin-type drugs.

Product name	Lincomycin hydrochloride API
Appearance	Off-white crystalline powder
CAS	859-18-7
EINECS	212-726-7
Assay	Not less than 790ug/mg Lincomycin, tested according to USP43
Shelf Life	36 months when properly stored
Storage	Keep in a cool, dry, dark location

 

Company Profile

Our Team

Office & Factory 

Our Certificates

 

 

Advanced production equipment

Quality Control 

Stock and Shipping

Our Customers